My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    Cancer Treat Res. 2009;151:197-215.

    Lapatinib: New Directions in HER2 Directed Therapy for Early Stage Breast Cancer.

    Jo Chien A, Rugo HS.

    University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, California, San Francisco, US, kruddy@partners.org.

    PMID: 19593514 [PubMed - in process]

    LinkOut - more resources

    Libraries:

    Supplemental Content

    Click here to read

    Related articles

    Patient drug information

    • Lapatinib (Tykerb®)

      Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is in a class of medications called ki...

    • Source: AHFS Consumer Medication Information

    Recent activity